Kodiak Sciences is trading at $95.25, up +4.30%, with broader biotech strength as context, not a confirmed cause.
- Biotech was up 2.18% in the supplied market data.
- No new Kodiak Sciences announcement explaining the October 28 move surfaced in the search.
- Its recent major catalyst was positive Phase 3 DAYBREAK data announced September 28, not a new event today.